Semaglutide 10mg

★★★★★

This listing is for 1 × Semaglutide 10mg vial only. Semaglutide is a selective glucagon-like peptide-1 (GLP-1) receptor agonist supplied as a lyophilised analytical reference material for incretin receptor signalling studies, glucose homeostasis mechanism research, and metabolic pathway regulation investigations in experimental models. Specifications include ≥99% purity, lyophilised white powder form, and storage at -20°C (long-term). Batch-specific analytical documentation is available via the Current Batch panel.

Research Use Only: This product is strictly for laboratory research and is not intended for human or veterinary consumption, therapeutic use, diagnostic use, or clinical application.

Useful Resources: Concentration Calculator | Semaglutide Research Overview | GLP-1 Research Overview | CagriSema vs Semaglutide | COA & Lab Testing

Current Batch

SOL-SEM-010Now Shipping

This batch has third party test results

4 Tests Available

Test Summary

Purity

99.90%

HPLC

Pass

Identity

Confirmed

LC-MS

Pass

Net Peptide Content

10.29 mg

Pass

Fentanyl Screen

Not Detected

Safety screen

Pass

Verified by ILS Laboratories|ISO/IEC 17025 Accredited

Official COA Verification

Independent Lab Verification

Scan the QR code to verify this certificate directly on the ILS Laboratories secure portal.

Access Code

573XELB4

$109.95 AUD

Quantity

Product Overview

Understanding Semaglutide 10mg

Semaglutide 10mg is a selective glucagon-like peptide-1 (GLP-1) receptor agonist supplied as a single-vial lyophilised analytical reference material for in-vitro laboratory research. This selective GLP-1 profile makes Semaglutide a relevant tool for researchers investigating incretin receptor signalling, glucose homeostasis mechanisms, and comparative single versus dual agonist pharmacology in laboratory models. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation.

Research Applications

•Selective GLP-1 Receptor Binding and Activation Studies: Investigate GLP-1 receptor binding kinetics and downstream incretin signalling pathway activation in experimental models.
•Comparative Incretin Receptor Pharmacology: Compare Semaglutide selective GLP-1 agonism against dual agonist controls in receptor binding and activation assays.
•Glucose Homeostasis and Insulin Secretion Investigation: Study GLP-1 receptor-mediated insulin secretion mechanisms and glucose homeostasis pathway regulation in vitro.
•Metabolic Signalling Pathway Analysis: Examine GLP-1 receptor downstream effector signalling at 0.1 nM to 100 nM analytical range in cell-based models.
This analytical standard is strictly for in-vitro laboratory research use only.

Technical Specifications

Technical Parameter

Laboratory Specification

Purity

≥99% based on available third-party documentation

Molecular Formula

C₁₈₇H₂₉₁N₄₅O₅₉

Molecular Weight

4113.64 g/mol

CAS Number

910463-68-2

Appearance

White Lyophilised Powder

Batch-specific third-party documentation available. Reports may include testing from independent laboratories such as Janoshik, Chromate, and Freedom Diagnostics, depending on the batch. View our COA & Lab Testing page for details.